Your browser doesn't support javascript.
loading
Protocol for a randomized controlled trial of sitting reduction to improve cardiometabolic health in older adults.
Rosenberg, Dori E; Greenwood-Hickman, Mikael Anne; Zhou, Jing; Cook, Andrea J; Mettert, Kayne D; Cooper, Julie; Arterburn, David; Green, Beverly B; Walsh-Bailey, Callie; Kerr, Jacqueline; Owen, Neville; Dunstan, David; McClure, Jennifer B.
Afiliación
  • Rosenberg DE; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Dori.E.Rosenberg@kp.org.
  • Greenwood-Hickman MA; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Mikael.Anne.Greenwood-Hickman@kp.org.
  • Zhou J; Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Jing.Zhou@kp.org.
  • Cook AJ; Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Andrea.J.Cook@kp.org.
  • Mettert KD; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Kayne.D.Mettert@kp.org.
  • Cooper J; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Julie.B.Cooper@kp.org.
  • Arterburn D; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: David.E.Arterburn@kp.org.
  • Green BB; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Bev.B.Green@kp.org.
  • Walsh-Bailey C; Brown School, Washington University in St. Louis, Campus Box 1196, One Brookings Drive, St. Louis, MO 63130, United States of America. Electronic address: callie.w@wustl.edu.
  • Kerr J; The Grant Doctor, San Diego, CA, United States of America. Electronic address: jkerr@grantdoctor.org.
  • Owen N; Baker Heart and Diabetes Institute, PO Box 6492, Melbourne, Victoria 3004, Australia. Electronic address: Neville.Owen@baker.edu.au.
  • Dunstan D; Baker Heart and Diabetes Institute, PO Box 6492, Melbourne, Victoria 3004, Australia; Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia. Electronic address: David.Dunstan@baker.edu.au.
  • McClure JB; Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave Suite 1600, Seattle, WA 98101, United States of America. Electronic address: Jennifer.B.McClure@kp.org.
Contemp Clin Trials ; 111: 106593, 2021 12.
Article en En | MEDLINE | ID: mdl-34666182
ABSTRACT
Older adults with obesity spend the majority of their waking hours sedentary. Given substantial barriers to regular physical activity in this population, approaches to reduce sedentary time could be an effective health promotion strategy. We present the protocol of a randomized controlled trial to reduce sitting time in older adults with a body mass index of 30 kg/m2 or above. Participants (N = 284) will be randomized to receive a sitting reduction intervention (termed I-STAND) or a healthy living focused attention control condition. I-STAND includes 10 contacts with a health coach (10 sessions total) and participants receive a wrist-worn prompting device and portable standing desk. The healthy living condition includes 10 sessions with a health coach to set goals around various topics relating to healthy aging. Participants receive their assigned intervention for 6 months. After 6 months, those receiving the I-STAND condition are re-randomized to receive five booster health coaching sessions by 'phone or no further contact; healthy living participants receive no further contact and those in both conditions are followed for an additional 6 months. Measurements initially included wearing an activPAL device and completing several biometric tests (e.g., blood pressure, HbA1c), at baseline, 3 months, 6 months, and 12 months; however, during the COVID-19 pandemic we shifted to remote assessments and were unable to collect all of these measures. The primary outcomes remained activPAL-assessed sitting time and blood pressure. Recruitment is anticipated to be completed in 2022.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / COVID-19 Tipo de estudio: Clinical_trials Límite: Aged / Humans Idioma: En Revista: Contemp Clin Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2021 Tipo del documento: Article